HOT NEWS
Bayer HealthCare joins forces with Stroke Alliance for Europe » Ahead of the "Move for Health Day" (10 May) and the "European Stroke Day" (14 May), the Stroke Allia...
Sanofi strengthens its French-German partnership » Sanofi (EURONEXT: SAN and NYSE: SNY) announced its involvement in two major Franco-German projects ...
Merck Serono to finance the launch of the EspeRare Foundation » Merck Serono, a division of Merck, Darmstadt, Germany, today announced the launch of the EspeRare Fo...
Bayer HealthCare to broaden strategic alliance with German Cancer Research Cente... » Bayer HealthCare (Bayer) and the German Cancer Research Center (DKFZ) will extend their successful s...
AstraZeneca and Karolinska Institutet to create Integrated Translational Researc... » AstraZeneca and the Swedish medical university Karolinska Institutet announced today their intention...
Innovative cervical screening app launches in UK and Ireland » The new Roche cobas® HPV Test app for iPad, which provides essential information about cervical can...
Roche obtains EU approval for PERJETA, a new personalised treatment for aggressi... » Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) has appr...
Novartis receives EU approval for Ilaris® in patients suffering acute gouty art... » Novartis announced that the European Commission (EC) has approved llaris (canakinumab, ACZ885) in th...
Genzyme Receives Company Award from European Organisation for Rare Diseases (EUR... » Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), ahas received a Company Award from EURORDIS...
Bayer supports innovative drug discovery in Europe » Bayer HealthCare initiated and will coordinate a newly founded pan-European consortium, named Europe...
Bristol-Myers Squibb
Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life. For more information, visit www.bms.com.

Bristol-Myers Squibb RSS Channel
Title Filter     Display # 
# Article Title Hits
1 Forxiga™ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes 3919
2 Bristol-Myers Squibb Foundation Announces Six New Grants 5430
3 Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban 6734
4 Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement 8163
5 APPRAISE-2 Study with Investigational Compound Apixaban Discontinued 11218
6 Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation 10741
7 Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® 11074
8 New Online Resource Launches For Patients With Chronic Myeloid Leukemia 10722
9 Bristol-Myers Squibb Enters Global Collaboration with Nissan Chemical and Teijin Pharma 11327
10 Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb 10110